Neolacta Life Sciences helps over one lakh preterm Infants in India, reaching a major milestone

Mumbai, January 30 2024: With their line of premium human milk products, Neolacta Lifesciences, a pioneering company committed to enhancing the health and lives of preterm newborns, has announced a noteworthy accomplishment: they have favourably impacted the lives of over a lakh premature infants throughout India. Over one-fifth of all births worldwide occur before full term, with an estimated 3 million preterm births occurring annually in India. Preterm birth is a serious public health hazard.

The company has launched a nationwide programme named "LAKH-shya" to honour the invaluable contributions of preterm baby parents, donor mothers, and healthcare professionals (HCPs) in honour of this historic milestone. Their steadfast dedication to implementing an Exclusive Human Milk Diet (EHMD) is acknowledged and celebrated by this initiative, which represents a critical turning point in their progress towards improved newborn nutrition.

Speaking on achieving this milestone, Sunil Sreekakula, Country GM of NeoLacta Lifesciences said, “We are delighted with our initial achievement, recognizing that our impact extends beyond our products. We believe that we have played a vital role in generating awareness about human milk benefits for preterm infants. The proliferation of human milk banks in India is evidence of the collective effort of all stakeholders in prioritizing the nutritional needs of preterm infants. Buoyed by our success, we are committed to marching ahead setting an ambitious goal to impact 1 million babies by 2030. Our journey continues as we strive to make a lasting and positive difference in the lives of these little ones, ensuring a healthier start for the next generation."
Acknowledging the challenges faced by mothers of preterm infants in producing 100% sufficient breast milk, Neolacta Lifesciences has pioneered a revolutionary line of human milk-based products. As the first company in Asia to comprehensively address the nutritional requirements of preterm infants, Neolacta has played a pivotal role in supporting families during this challenging period.